Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0002076816-25-000001
Filing Date
2025-08-07
Accepted
2025-08-07 17:02:03
Documents
1
Effectiveness Date
2025-08-07
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8606
  Complete submission text file 0002076816-25-000001.txt   9809
Mailing Address 1800 TYSONS BLVD, SUITE 900 MCLEAN VA 22102
Business Address 1800 TYSONS BLVD, SUITE 900 MCLEAN VA 22102 650-843-5000
Red Cell Incubation Fund II, L.P. (Filer) CIK: 0002076816 (see all company filings)

EIN.: 334640034 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-554057 | Film No.: 251195180